Search research articles
Contact Us
Filters
Showing results (791-800 of 900) with videos related to
Page
of 90
Sort By:
The Journal of Experimental Medicine
|
February 24, 2001
Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation
Y Kawazoe, T Naka, M Fujimoto, et al.
Immunity
|
May 24, 2001
SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo
T Naka, H Tsutsui, M Fujimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 11, 2001
[High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study]
H Kitajima, K Nasu, M Tsudo, et al.
Neuropathology and Applied Neurobiology
|
April 9, 2019
Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases
M Inoue, J Tanboon, M Okubo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2019
CD103 negative memory T cells may play important roles in making regulatory T-cell-enriched environments in skin tumours
Y Nakamura, R Watanabe, Z Zhenjie, et al.
Clinical and Experimental Rheumatology
|
November 18, 2009
Autoantibody against activating transcription factor-2 in patients with systemic sclerosis
Y Akiyama, F Ogawa, Y Iwata, et al.
The British Journal of Dermatology
|
July 26, 2016
Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
T Matsushita, K Mizumaki, M Kano, et al.
Chemical & Pharmaceutical Bulletin
|
August 6, 1999
Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists: pyrazolo[1,5-a]pyrimidine derivatives
T Shiota, T Yamamori, K Sakai, et al.
Chemical & Pharmaceutical Bulletin
|
February 1, 1996
Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives
K Sakurawi, F Yasuda, T Tozyo, et al.
The British Journal of Dermatology
|
January 22, 2008
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis
Y Hamaguchi, M Hasegawa, M Fujimoto, et al.
Page
of 90
Search research articles
Search
Showing results (791-800 of 900) with videos related to
Sort By:
Page
of 90
The Journal of Experimental Medicine
|
February 24, 2001
Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation
Y Kawazoe, T Naka, M Fujimoto, et al.
Immunity
|
May 24, 2001
SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo
T Naka, H Tsutsui, M Fujimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 11, 2001
[High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study]
H Kitajima, K Nasu, M Tsudo, et al.
Neuropathology and Applied Neurobiology
|
April 9, 2019
Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases
M Inoue, J Tanboon, M Okubo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2019
CD103 negative memory T cells may play important roles in making regulatory T-cell-enriched environments in skin tumours
Y Nakamura, R Watanabe, Z Zhenjie, et al.
Clinical and Experimental Rheumatology
|
November 18, 2009
Autoantibody against activating transcription factor-2 in patients with systemic sclerosis
Y Akiyama, F Ogawa, Y Iwata, et al.
The British Journal of Dermatology
|
July 26, 2016
Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
T Matsushita, K Mizumaki, M Kano, et al.
Chemical & Pharmaceutical Bulletin
|
August 6, 1999
Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists: pyrazolo[1,5-a]pyrimidine derivatives
T Shiota, T Yamamori, K Sakai, et al.
Chemical & Pharmaceutical Bulletin
|
February 1, 1996
Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives
K Sakurawi, F Yasuda, T Tozyo, et al.
The British Journal of Dermatology
|
January 22, 2008
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis
Y Hamaguchi, M Hasegawa, M Fujimoto, et al.
Page
of 90